Spago Nanomedical
0,2
SEK
-6,54 %
Mindre end 1K følgere
SPAGO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
Spago Nanomedical conducts research and development in cancer diagnostics. The company conducts various development projects based on its proprietary nanomaterials whose potential is found in making tumours visible, and enabling internal radiation therapy of cancer. The company was founded in 2007 and is based in Lund.
Læs mereMarkedsværdi
69,64 mio. SEK
Aktieomsætning
57,43 t SEK
Omsætning
1,91 mio.
EBIT %
-1.764,92 %
P/E
-
Udbytteafkast, %
-
Finanskalender
20.8
2025
Delårsrapport Q2'25
5.11
2025
Delårsrapport Q3'25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
DNB Carnegie Access: Spago Nanomedical: Intervju - Närmar sig viktiga resultat
DNB Carnegie Access: Spago Nanomedical: DMC gives green light to proceed
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools